Inhibition of pro-inflammatory signaling in human primary macrophages by enhancing arginase-2 via target site blockers
The modulation of macrophage phenotype from a pro-inflammatory to an anti-inflammatory state holds therapeutic potential in the treatment of inflammatory disease. We have previously shown that arginase-2 (Arg2), a mitochondrial enzyme, is a key regulator of the macrophage anti-inflammatory response....
Saved in:
Published in | Molecular therapy. Nucleic acids Vol. 33; pp. 941 - 959 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
12.09.2023
American Society of Gene & Cell Therapy Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The modulation of macrophage phenotype from a pro-inflammatory to an anti-inflammatory state holds therapeutic potential in the treatment of inflammatory disease. We have previously shown that arginase-2 (Arg2), a mitochondrial enzyme, is a key regulator of the macrophage anti-inflammatory response. Here, we investigate the therapeutic potential of Arg2 enhancement via target site blockers (TSBs) in human macrophages. TSBs are locked nucleic acid antisense oligonucleotides that were specifically designed to protect specific microRNA recognition elements (MREs) in human ARG2 3′ UTR mRNA. TSBs targeting miR-155 (TSB-155) and miR-3202 (TSB-3202) MREs increased ARG2 expression in human monocyte-derived macrophages. This resulted in decreased gene expression and cytokine production of TNF-α and CCL2 and, for TSB-3202, in an increase in the anti-inflammatory macrophage marker, CD206. Proteomic analysis demonstrated that a network of pro-inflammatory responsive proteins was modulated by TSBs. In silico bioinformatic analysis predicted that TSB-3202 suppressed upstream pro-inflammatory regulators including STAT-1 while enhancing anti-inflammatory associated proteins. Proteomic data were validated by confirming increased levels of sequestosome-1 and decreased levels of phosphorylated STAT-1 and STAT-1 upon TSB treatment. In conclusion, upregulation of Arg2 by TSBs inhibits pro-inflammatory signaling and is a promising novel therapeutic strategy to modulate inflammatory signaling in human macrophages.
[Display omitted]
Fitzsimons and colleagues demonstrated that arginase-2 is increased by IL-10 in the presence of a pro-inflammatory stimulus in human primary macrophages. We designed oligonucleotides (target site blockers) that could block microRNA binding to arginase-2 messenger RNA. This led to enhancement of arginase-2 and a decrease in pro-inflammatory signaling. |
---|---|
AbstractList | The modulation of macrophage phenotype from a pro-inflammatory to an anti-inflammatory state holds therapeutic potential in the treatment of inflammatory disease. We have previously shown that arginase-2 (Arg2), a mitochondrial enzyme, is a key regulator of the macrophage anti-inflammatory response. Here, we investigate the therapeutic potential of Arg2 enhancement via target site blockers (TSBs) in human macrophages. TSBs are locked nucleic acid antisense oligonucleotides that were specifically designed to protect specific microRNA recognition elements (MREs) in human ARG2 3′ UTR mRNA. TSBs targeting miR-155 (TSB-155) and miR-3202 (TSB-3202) MREs increased ARG2 expression in human monocyte-derived macrophages. This resulted in decreased gene expression and cytokine production of TNF-α and CCL2 and, for TSB-3202, in an increase in the anti-inflammatory macrophage marker, CD206. Proteomic analysis demonstrated that a network of pro-inflammatory responsive proteins was modulated by TSBs. In silico bioinformatic analysis predicted that TSB-3202 suppressed upstream pro-inflammatory regulators including STAT-1 while enhancing anti-inflammatory associated proteins. Proteomic data were validated by confirming increased levels of sequestosome-1 and decreased levels of phosphorylated STAT-1 and STAT-1 upon TSB treatment. In conclusion, upregulation of Arg2 by TSBs inhibits pro-inflammatory signaling and is a promising novel therapeutic strategy to modulate inflammatory signaling in human macrophages.
[Display omitted]
Fitzsimons and colleagues demonstrated that arginase-2 is increased by IL-10 in the presence of a pro-inflammatory stimulus in human primary macrophages. We designed oligonucleotides (target site blockers) that could block microRNA binding to arginase-2 messenger RNA. This led to enhancement of arginase-2 and a decrease in pro-inflammatory signaling. The modulation of macrophage phenotype from a pro-inflammatory to an anti-inflammatory state holds therapeutic potential in the treatment of inflammatory disease. We have previously shown that arginase-2 (Arg2), a mitochondrial enzyme, is a key regulator of the macrophage anti-inflammatory response. Here, we investigate the therapeutic potential of Arg2 enhancement via target site blockers (TSBs) in human macrophages. TSBs are locked nucleic acid antisense oligonucleotides that were specifically designed to protect specific microRNA recognition elements (MREs) in human ARG2 3′ UTR mRNA. TSBs targeting miR-155 (TSB-155) and miR-3202 (TSB-3202) MREs increased ARG2 expression in human monocyte-derived macrophages. This resulted in decreased gene expression and cytokine production of TNF-α and CCL2 and, for TSB-3202, in an increase in the anti-inflammatory macrophage marker, CD206. Proteomic analysis demonstrated that a network of pro-inflammatory responsive proteins was modulated by TSBs. In silico bioinformatic analysis predicted that TSB-3202 suppressed upstream pro-inflammatory regulators including STAT-1 while enhancing anti-inflammatory associated proteins. Proteomic data were validated by confirming increased levels of sequestosome-1 and decreased levels of phosphorylated STAT-1 and STAT-1 upon TSB treatment. In conclusion, upregulation of Arg2 by TSBs inhibits pro-inflammatory signaling and is a promising novel therapeutic strategy to modulate inflammatory signaling in human macrophages. Fitzsimons and colleagues demonstrated that arginase-2 is increased by IL-10 in the presence of a pro-inflammatory stimulus in human primary macrophages. We designed oligonucleotides (target site blockers) that could block microRNA binding to arginase-2 messenger RNA. This led to enhancement of arginase-2 and a decrease in pro-inflammatory signaling. The modulation of macrophage phenotype from a pro-inflammatory to an anti-inflammatory state holds therapeutic potential in the treatment of inflammatory disease. We have previously shown that arginase-2 (Arg2), a mitochondrial enzyme, is a key regulator of the macrophage anti-inflammatory response. Here, we investigate the therapeutic potential of Arg2 enhancement via target site blockers (TSBs) in human macrophages. TSBs are locked nucleic acid antisense oligonucleotides that were specifically designed to protect specific microRNA recognition elements (MREs) in human ARG2 3' UTR mRNA. TSBs targeting miR-155 (TSB-155) and miR-3202 (TSB-3202) MREs increased ARG2 expression in human monocyte-derived macrophages. This resulted in decreased gene expression and cytokine production of TNF-α and CCL2 and, for TSB-3202, in an increase in the anti-inflammatory macrophage marker, CD206. Proteomic analysis demonstrated that a network of pro-inflammatory responsive proteins was modulated by TSBs. In silico bioinformatic analysis predicted that TSB-3202 suppressed upstream pro-inflammatory regulators including STAT-1 while enhancing anti-inflammatory associated proteins. Proteomic data were validated by confirming increased levels of sequestosome-1 and decreased levels of phosphorylated STAT-1 and STAT-1 upon TSB treatment. In conclusion, upregulation of Arg2 by TSBs inhibits pro-inflammatory signaling and is a promising novel therapeutic strategy to modulate inflammatory signaling in human macrophages.The modulation of macrophage phenotype from a pro-inflammatory to an anti-inflammatory state holds therapeutic potential in the treatment of inflammatory disease. We have previously shown that arginase-2 (Arg2), a mitochondrial enzyme, is a key regulator of the macrophage anti-inflammatory response. Here, we investigate the therapeutic potential of Arg2 enhancement via target site blockers (TSBs) in human macrophages. TSBs are locked nucleic acid antisense oligonucleotides that were specifically designed to protect specific microRNA recognition elements (MREs) in human ARG2 3' UTR mRNA. TSBs targeting miR-155 (TSB-155) and miR-3202 (TSB-3202) MREs increased ARG2 expression in human monocyte-derived macrophages. This resulted in decreased gene expression and cytokine production of TNF-α and CCL2 and, for TSB-3202, in an increase in the anti-inflammatory macrophage marker, CD206. Proteomic analysis demonstrated that a network of pro-inflammatory responsive proteins was modulated by TSBs. In silico bioinformatic analysis predicted that TSB-3202 suppressed upstream pro-inflammatory regulators including STAT-1 while enhancing anti-inflammatory associated proteins. Proteomic data were validated by confirming increased levels of sequestosome-1 and decreased levels of phosphorylated STAT-1 and STAT-1 upon TSB treatment. In conclusion, upregulation of Arg2 by TSBs inhibits pro-inflammatory signaling and is a promising novel therapeutic strategy to modulate inflammatory signaling in human macrophages. The modulation of macrophage phenotype from a pro-inflammatory to an anti-inflammatory state holds therapeutic potential in the treatment of inflammatory disease. We have previously shown that arginase-2 (Arg2), a mitochondrial enzyme, is a key regulator of the macrophage anti-inflammatory response. Here, we investigate the therapeutic potential of Arg2 enhancement via target site blockers (TSBs) in human macrophages. TSBs are locked nucleic acid antisense oligonucleotides that were specifically designed to protect specific microRNA recognition elements (MREs) in human ARG2 3′ UTR mRNA. TSBs targeting miR-155 (TSB-155) and miR-3202 (TSB-3202) MREs increased ARG2 expression in human monocyte-derived macrophages. This resulted in decreased gene expression and cytokine production of TNF-α and CCL2 and, for TSB-3202, in an increase in the anti-inflammatory macrophage marker, CD206. Proteomic analysis demonstrated that a network of pro-inflammatory responsive proteins was modulated by TSBs. In silico bioinformatic analysis predicted that TSB-3202 suppressed upstream pro-inflammatory regulators including STAT-1 while enhancing anti-inflammatory associated proteins. Proteomic data were validated by confirming increased levels of sequestosome-1 and decreased levels of phosphorylated STAT-1 and STAT-1 upon TSB treatment. In conclusion, upregulation of Arg2 by TSBs inhibits pro-inflammatory signaling and is a promising novel therapeutic strategy to modulate inflammatory signaling in human macrophages. |
Author | Ramió-Torrentà, Lluís Nally, Frances Fitzsimons, Stephen Dillon, Eugene Strowitzki, Moritz J. McCoy, Claire E. Fashina, Ifeolutembi A. De Santi, Chiara Muñoz-San Martín, María Dowling, Jennifer K. |
Author_xml | – sequence: 1 givenname: Stephen surname: Fitzsimons fullname: Fitzsimons, Stephen email: sfitzsimons08@gmail.com organization: School of Pharmacy and Biomolecular Science, Royal College of Surgeons in Ireland, 123 St Stephen’s Green, Dublin 2, Ireland – sequence: 2 givenname: María surname: Muñoz-San Martín fullname: Muñoz-San Martín, María organization: School of Pharmacy and Biomolecular Science, Royal College of Surgeons in Ireland, 123 St Stephen’s Green, Dublin 2, Ireland – sequence: 3 givenname: Frances surname: Nally fullname: Nally, Frances organization: School of Pharmacy and Biomolecular Science, Royal College of Surgeons in Ireland, 123 St Stephen’s Green, Dublin 2, Ireland – sequence: 4 givenname: Eugene surname: Dillon fullname: Dillon, Eugene organization: School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland – sequence: 5 givenname: Ifeolutembi A. surname: Fashina fullname: Fashina, Ifeolutembi A. organization: School of Pharmacy and Biomolecular Science, Royal College of Surgeons in Ireland, 123 St Stephen’s Green, Dublin 2, Ireland – sequence: 6 givenname: Moritz J. surname: Strowitzki fullname: Strowitzki, Moritz J. organization: Department of General, Visceral & Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany – sequence: 7 givenname: Lluís surname: Ramió-Torrentà fullname: Ramió-Torrentà, Lluís organization: Neuroinflammation and Neurodegeneration Group, Girona Biomedical Research Institute (IDIBGI), CERCA Programme/Generalitat de Catalunya, Salt, Girona, Spain – sequence: 8 givenname: Jennifer K. surname: Dowling fullname: Dowling, Jennifer K. organization: School of Pharmacy and Biomolecular Science, Royal College of Surgeons in Ireland, 123 St Stephen’s Green, Dublin 2, Ireland – sequence: 9 givenname: Chiara surname: De Santi fullname: De Santi, Chiara email: chiaradesanti@rcsi.ie organization: School of Pharmacy and Biomolecular Science, Royal College of Surgeons in Ireland, 123 St Stephen’s Green, Dublin 2, Ireland – sequence: 10 givenname: Claire E. surname: McCoy fullname: McCoy, Claire E. organization: School of Pharmacy and Biomolecular Science, Royal College of Surgeons in Ireland, 123 St Stephen’s Green, Dublin 2, Ireland |
BookMark | eNp9kcFu3CAQhq0qlZqmeYGeOPZiF7CNsVSpqqKmXSlSL-0ZDTD2srVhC-xKefuw3VWVXAqHGZh_PoaZt9WVDx6r6j2jDaNMfNw1Yc2-4ZS3DZVNMa-qa84Er3nfsqtn_pvqNqUdLUtQxgW_ro4bv3XaZRc8CRPZx1A7Py2wrpBDfCTJzR4W52fiPNkeVvBF41YooRVMDPstzJiIfiTot-DNSQlxdh4S1pwcHZBczpgLKSPRSzC_MaZ31esJloS3F3tT_br_-vPue_3w49vm7stDbbqe5lqOLbVW8okZHAYL1DDQ1vQ4UjuClJYPlLJeGMnYqDUMrO8sm6RoqZGG9u1NtTlzbYCdulSuAjj19yLEWUHMziyoWNsPYGEynOlO0G4cNJQ96ElbSaehsD6fWfuDXtEa9DnC8gL6MuLdVs3hqFiBdS0bC-HDhRDDnwOmrFaXDC4LeAyHpLgUnWClelGk_CwtPU4p4vTvHUbVaeqqVF-mrk5TV1SqYkrSp3MSlpYeHUaVjENv0LqIJpc_u_-lPwG9dLso |
Cites_doi | 10.1074/jbc.275.3.1708 10.4049/jimmunol.160.3.1411 10.1172/JCI115102 10.1212/WNL.53.3.457 10.1186/s12974-016-0513-y 10.1002/jcb.27259 10.1084/jem.193.6.713 10.3389/fimmu.2017.01097 10.1523/JNEUROSCI.3257-09.2009 10.1186/s12974-021-02125-y 10.1038/nprot.2007.261 10.1038/nbt.1511 10.3390/ijms19071953 10.1111/j.1365-2567.2011.03541.x 10.1161/CIRCULATIONAHA.117.031589 10.1016/j.cyto.2018.12.015 10.1093/nar/gkab1038 10.1038/s41467-018-05800-6 10.1111/j.1365-2567.2008.02881.x 10.4049/jimmunol.1103608 10.1136/gutjnl-2015-310514 10.1189/jlb.69.4.598 10.3390/ijms21155291 10.1158/1535-7163.MCT-16-0124 10.1146/annurev-immunol-032713-120231 10.18632/oncotarget.17256 10.1016/j.cell.2015.12.057 10.1038/nmeth.3901 10.3389/fimmu.2020.576516 10.1016/S0165-5728(98)00002-2 10.1074/jbc.M605237200 10.1016/j.canlet.2018.02.026 10.1093/ndt/13.6.1412 10.1038/s41467-021-21617-2 10.1146/annurev.neuro.30.051606.094313 10.7150/ijbs.5613 10.1038/nrrheum.2015.169 10.18632/aging.101470 10.1016/j.jneuroim.2018.02.015 10.1002/path.4133 10.4049/jimmunol.180.11.7376 10.1093/emboj/17.13.3660 10.1016/S1044-5323(02)00125-2 10.1161/CIRCRESAHA.116.309194 10.1093/bfgp/elt028 10.1016/j.immuni.2013.02.012 10.1038/nprot.2016.136 10.4049/jimmunol.1100663 10.4049/jimmunol.148.8.2423 10.1016/j.smim.2015.07.003 10.1007/s12035-016-9846-x 10.3389/fimmu.2020.574046 10.1007/s00726-016-2231-2 10.1038/s41467-017-00813-z 10.1038/srep13414 10.1371/journal.pone.0265196 10.1016/S0165-5728(01)00487-8 10.4049/jimmunol.1000491 10.4049/jimmunol.1100963 10.1182/blood-2012-12-473017 10.4049/jimmunol.164.12.6166 10.1016/j.omtn.2022.08.004 10.1038/s41598-021-88448-5 10.1126/scisignal.aad5614 10.1038/nri3088 10.1038/ncomms10521 10.3389/fimmu.2014.00614 10.1016/j.ymthe.2020.02.001 10.4161/15548627.2014.981789 10.1016/j.immuni.2014.06.008 10.1016/S1074-7613(00)80412-4 10.1016/j.addr.2014.12.006 10.3389/fimmu.2019.02759 10.1073/pnas.0902636106 10.18632/oncotarget.14841 10.1016/S0165-5728(97)00208-7 10.1074/mcp.M113.031591 10.1016/j.tips.2018.03.001 10.1016/j.xcrm.2020.100053 10.1038/nn738 10.1021/pr101065j 10.1038/s41467-018-05065-z 10.1146/annurev-immunol-032713-120227 10.1155/2019/6724903 10.1126/sciimmunol.abf2846 10.1084/jem.170.2.607 10.1074/jbc.M110.118976 10.1021/acs.jproteome.7b00828 10.1096/fj.12-215442 10.3389/fimmu.2017.01062 10.3390/cells9102290 |
ContentType | Journal Article |
Copyright | 2023 The Authors 2023 The Authors. 2023 The Authors 2023 |
Copyright_xml | – notice: 2023 The Authors – notice: 2023 The Authors. – notice: 2023 The Authors 2023 |
DBID | 6I. AAFTH AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1016/j.omtn.2023.08.023 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 2162-2531 |
EndPage | 959 |
ExternalDocumentID | oai_doaj_org_article_1357adafc21b460497babab7bfbd80f7 10_1016_j_omtn_2023_08_023 S2162253123002342 |
GroupedDBID | 0R~ 0SF 53G 5VS 6I. 7X7 8FE 8FH 8FI AACTN AAEDW AAFTH AALRI AAXUO ABMAC ACGFS ADBBV AEXQZ AFKRA AFTJW AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS AZQEC BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI DIK EBS FDB FYUFA GROUPED_DOAJ HCIFZ KQ8 LK8 M2P M41 M48 M7P M~E NCXOZ O9- OK1 PIMPY PQQKQ PROAC RNTTT ROL RPM SSZ 3V. 88A 88I 8FJ AAMRU AAYXX ABUWG ADRAZ ADVLN ALIPV CCPQU CITATION DWQXO EJD GNUQQ HMCUK HYE IPNFZ M0L RIG UKHRP 7X8 5PM |
ID | FETCH-LOGICAL-c450t-8930dd82f1ce77da0c1abdc5e90d9a88d2700156c8119bba7154d1f8630c8c053 |
IEDL.DBID | RPM |
ISSN | 2162-2531 |
IngestDate | Tue Oct 22 15:13:40 EDT 2024 Tue Sep 17 21:29:42 EDT 2024 Sat Oct 26 04:10:04 EDT 2024 Thu Nov 21 23:30:55 EST 2024 Fri Feb 23 02:35:54 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | MT: Oligonucleotides: Therapies and Applications macrophages inflammation miR-155 multiple sclerosis microRNA target site blockers arginase-2 |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c450t-8930dd82f1ce77da0c1abdc5e90d9a88d2700156c8119bba7154d1f8630c8c053 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494319/ |
PQID | 2864618636 |
PQPubID | 23479 |
PageCount | 19 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_1357adafc21b460497babab7bfbd80f7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10494319 proquest_miscellaneous_2864618636 crossref_primary_10_1016_j_omtn_2023_08_023 elsevier_sciencedirect_doi_10_1016_j_omtn_2023_08_023 |
PublicationCentury | 2000 |
PublicationDate | 2023-09-12 |
PublicationDateYYYYMMDD | 2023-09-12 |
PublicationDate_xml | – month: 09 year: 2023 text: 2023-09-12 day: 12 |
PublicationDecade | 2020 |
PublicationTitle | Molecular therapy. Nucleic acids |
PublicationYear | 2023 |
Publisher | Elsevier Inc American Society of Gene & Cell Therapy Elsevier |
Publisher_xml | – name: Elsevier Inc – name: American Society of Gene & Cell Therapy – name: Elsevier |
References | Hardbower, Asim, Murray-Stewart, Casero, Verriere, Lewis, Chaturvedi, Piazuelo, Wilson (bib50) 2016; 48 Simpson, Newcombe, Cuzner, Woodroofe (bib69) 1998; 84 Teng, Han, Zhang, Hsu, He, Wani, Barajas, Snyder, Frankel, Caligiuri (bib67) 2017; 16 Iarlori, Reale, De Luca, Di Iorio, Feliciani, Tulli, Conti, Gambi, Lugaresi (bib72) 2002; 123 McCarthy, Duffy, Mooney, James, Griffin, Fitzgerald, Belton (bib14) 2013; 27 Yin, Phạm, Shin, Shin, Kang, Lee, Lee, Kim, Kim, Hong (bib51) 2020; 9 Sergin, Bhattacharya, Emanuel, Esen, Stokes, Evans, Arif, Curci, Razani (bib88) 2016; 9 Jiang, Beller, Frendl, Graves (bib63) 1992; 148 Unuvar Purcu, Korkmaz, Gunalp, Helvaci, Erdal, Dogan, Suner, Wingender, Sag (bib13) 2022; 17 Wang, Liang, Zen (bib20) 2014; 5 Mantovani, Biswas, Galdiero, Sica, Locati (bib6) 2013; 229 Tyanova, Temu, Sinitcyn, Carlson, Hein, Geiger, Mann, Cox (bib96) 2016; 13 Peterson, Cottam, Kennedy, Hasty (bib4) 2018; 39 Raggi, Pelassa, Pierobon, Penco, Gattorno, Novelli, Eva, Varesio, Giovarelli, Bosco (bib11) 2017; 8 Self-Fordham, Naqvi, Uttamani, Kulkarni, Nares (bib19) 2017; 8 Schraufstatter, Zhao, Khaldoyanidi, Discipio (bib73) 2012; 135 Lawrence, Natoli (bib77) 2011; 11 O'Connell, Chaudhuri, Rao, Baltimore (bib33) 2009; 106 Korhonen, Piippo, Hytti, Hyttinen, Kaarniranta, Kauppinen (bib86) 2019; 116 Bi, Chen, Hu, Liu, Li, Zhao (bib15) 2019; 2019 Marathe, Bradley, Hong, Lopez, Ruiz de Galarreta, Tontonoz, Castrillo (bib52) 2006; 281 McManus, Berman, Brett, Staunton, Farrell, Brosnan (bib70) 1998; 86 Hofman, Hinton, Johnson, Merrill (bib45) 1989; 170 Nahrendorf, Swirski (bib9) 2016; 119 Fitzsimons, Oggero, Bruen, McCarthy, Strowitzki, Mahon, Ryan, Brennan, Barry, Perretti, Belton (bib10) 2020; 11 (bib56) 1999; 53 Schneider, Chevillotte, Rice (bib76) 2014; 32 Xiong, Yepuri, Forbiteh, Yu, Montani, Yang, Ming (bib85) 2014; 10 Steinman (bib41) 2014; 32 Zhou, Michal, Zhang, Ding, Lunney, Liu, Jiang (bib80) 2013; 9 Sonneville, Ruffin, Coraux, Rousselet, Le Rouzic, Blouquit-Laye, Corvol, Tabary (bib26) 2017; 8 Kallaur, Oliveira, Simão, Alfieri, Flauzino, Lopes, de Carvalho Jennings Pereira, de Meleck Proença, Borelli, Kaimen-Maciel (bib48) 2017; 54 Cox, Mann (bib90) 2008; 26 Wang, Hou, Lin, Wang, Liu, Li, Ma, Wang, Cao (bib34) 2010; 185 Simmons, Nguyen, Gomez-Rivas, Jeong, Jonsson, Chen, Lange, Dyer, Blazar, Earp (bib39) 2022; 7 Li, Yao, Yuan, Chen, Li, Li, Chu, Song, Xie, Jiang, Wang (bib68) 2017; 66 Hutchins, Diez, Miranda-Saavedra (bib35) 2013; 12 Dowling, Afzal, Gearing, Cervantes-Silva, Annett, Davis, De Santi, Assmann, Dettmer, Gough (bib30) 2021; 12 Dogan, Elhofy, Karpus (bib66) 2008; 180 Jain, Lamark, Sjøttem, Larsen, Awuh, Øvervatn, McMahon, Hayes, Johansen (bib84) 2010; 285 Valentin-Torres, Savarin, Hinton, Phares, Bergmann, Stohlman (bib49) 2016; 13 Al-Haidari, Algaber, Madhi, Syk, Thorlacius (bib54) 2018; 421 Ping, Jones, Boss (bib60) 1996; 4 Perez-Riverol, Bai, Bandla, García-Seisdedos, Hewapathirana, Kamatchinathan, Kundu, Prakash, Frericks-Zipper, Eisenacher (bib95) 2022; 50 Yin, Ma, Lin, Lu, Zhang, Chen, Jian (bib36) 2018; 119 Chu, Shi, Zheng, Shen, Zhu, Zheng, Cui (bib3) 2018; 318 Wei, Corbalán-Campos, Gurung, Natarelli, Zhu, Exner, Erhard, Greulich, Geißler, Uhlenhaut (bib23) 2018; 138 Shechter, Miller, Yovel, Rosenzweig, London, Ruckh, Kim, Klein, Kalchenko, Bendel (bib18) 2013; 38 Selmaj, Raine, Cannella, Brosnan (bib46) 1991; 87 Kim, Kim, Kim, Kwon, Kwon, Kang, Kim, Choi (bib75) 2015; 5 Cox, Neuhauser, Michalski, Scheltema, Olsen, Mann (bib92) 2011; 10 Beavers, Nelson, Duvall (bib21) 2015; 88 Fransson, Liljenfeldt, Fagius, Tötterman, Loskog (bib43) 2009; 126 Denney, Kok, Cole, Sanderson, McMichael, Ho (bib16) 2012; 189 Verma, Lam, Chiu, Tran, Hall, Hodgkinson (bib42) 2021; 11 Mahad, Ransohoff (bib71) 2003; 15 De Santi, Fernández Fernández, Gaul, Vencken, Glasgow, Oglesby, Hurley, Hawkins, Mitash, Mu (bib27) 2020; 28 Trapp, Nave (bib40) 2008; 31 Gschwandtner, Derler, Midwood (bib59) 2019; 10 Huang, Wang, Kivisakk, Rollins, Ransohoff (bib65) 2001; 193 Deutsch, Bandeira, Sharma, Perez-Riverol, Carver, Kundu, García-Seisdedos, Jarnuczak, Hewapathirana, Pullman (bib94) 2020; 48 Niespolo, Johnston, Deshmukh, Satam, Shologu, Villacanas, Sudbery, Wilson, Kiss-Toth (bib22) 2020; 11 Cox, Hein, Luber, Paron, Nagaraj, Mann (bib93) 2014; 13 Schett, Neurath (bib7) 2018; 9 Kigerl, Gensel, Ankeny, Alexander, Donnelly, Popovich (bib17) 2009; 29 Huang, Lewis, Borg, Canals, Diep, Drummond, Goode, Schittenhelm, Vinh, Zhu (bib38) 2018; 17 Fresegna, Bullitta, Musella, Rizzo, De Vito, Guadalupi, Caioli, Balletta, Sanna, Dolcetti (bib47) 2020; 9 Kalliolias, Ivashkiv (bib55) 2016; 12 Ponzoni, Pastorino, Di Paolo, Perri, Brignole (bib5) 2018; 19 Mills, Kincaid, Alt, Heilman, Hill (bib8) 2000; 164 Schultze, Schmieder, Goerdt (bib1) 2015; 27 Ko, Yoon, Lee, Oh (bib87) 2017; 8 De Santi, Nally, Afzal, Duffy, Fitzsimons, Annett, Robson, Dowling, Cryan, McCoy (bib31) 2022; 29 Tyanova, Temu, Cox (bib91) 2016; 11 Xia, Gu, Jia, Wang, Wu, Guo, Zhang, Du, Wang (bib83) 2018; 10 Zhong, Umemura, Sanchez-Lopez, Liang, Shalapour, Wong, He, Boassa, Perkins, Ali (bib37) 2016; 164 Kruglov, Lampropoulou, Fillatreau, Nedospasov (bib58) 2011; 187 Malaer, Mathew (bib82) 2017; 7 Hartmann, Zhou, Natarelli, Wei, Nazari-Jahantigh, Zhu, Grommes, Steffens, Weber, Schober (bib24) 2016; 7 Liu, Chen, Wei, Shan, Wang (bib81) 2011; 187 Parisi, Gini, Baci, Tremolati, Fanuli, Bassani, Farronato, Bruno, Mortara (bib2) 2018; 2018 Al-Haidari, Syk, Thorlacius (bib53) 2017; 8 Arnett, Mason, Marino, Suzuki, Matsushima, Ting (bib57) 2001; 4 Acquaviva, Menon, Di Dario, Dalla Costa, Romeo, Sangalli, Colombo, Moiola, Martinelli, Comi, Farina (bib44) 2020; 1 Murray, Allen, Biswas, Fisher, Gilroy, Goerdt, Gordon, Hamilton, Ivashkiv, Lawrence (bib12) 2014; 41 Fioranelli, Roccia (bib32) 2014; 1 Young, Ting, Li, Moller, Dunn, Lu, Moses, Prado-Lourenço, Khachigian, Ng (bib25) 2013; 122 Dansereau, Midavaine, Bégin-Lavallée, Belkouch, Beaudet, Longpré, Mélik-Parsadaniantz, Sarret (bib64) 2021; 18 Kodelja, Müller, Politz, Hakij, Orfanos, Goerdt (bib74) 1998; 160 Ping, Boekhoudt, Zhang, Morris, Philipsen, Warren, Boss (bib61) 2000; 275 Ohmori, Hamilton (bib78) 2001; 69 Rappsilber, Mann, Ishihama (bib89) 2007; 2 Natarelli, Geißler, Csaba, Wei, Zhu, di Francesco, Hartmann, Zimmer, Schober (bib28) 2018; 9 S Clemente, van Waarde, F Antunes, Dömling, H Elsinga (bib29) 2020; 21 Bauermeister, Burger, Almanasreh, Knopf, Schumann, Schollmeyer, Dobos (bib62) 1998; 13 Kovarik, Stoiber, Novy, Decker (bib79) 1998; 17 Yin (10.1016/j.omtn.2023.08.023_bib36) 2018; 119 Kalliolias (10.1016/j.omtn.2023.08.023_bib55) 2016; 12 De Santi (10.1016/j.omtn.2023.08.023_bib31) 2022; 29 Marathe (10.1016/j.omtn.2023.08.023_bib52) 2006; 281 Fitzsimons (10.1016/j.omtn.2023.08.023_bib10) 2020; 11 Gschwandtner (10.1016/j.omtn.2023.08.023_bib59) 2019; 10 Huang (10.1016/j.omtn.2023.08.023_bib65) 2001; 193 Natarelli (10.1016/j.omtn.2023.08.023_bib28) 2018; 9 Cox (10.1016/j.omtn.2023.08.023_bib93) 2014; 13 Young (10.1016/j.omtn.2023.08.023_bib25) 2013; 122 Cox (10.1016/j.omtn.2023.08.023_bib90) 2008; 26 Hartmann (10.1016/j.omtn.2023.08.023_bib24) 2016; 7 Kallaur (10.1016/j.omtn.2023.08.023_bib48) 2017; 54 Kigerl (10.1016/j.omtn.2023.08.023_bib17) 2009; 29 Al-Haidari (10.1016/j.omtn.2023.08.023_bib53) 2017; 8 Tyanova (10.1016/j.omtn.2023.08.023_bib91) 2016; 11 McManus (10.1016/j.omtn.2023.08.023_bib70) 1998; 86 Liu (10.1016/j.omtn.2023.08.023_bib81) 2011; 187 Yin (10.1016/j.omtn.2023.08.023_bib51) 2020; 9 O'Connell (10.1016/j.omtn.2023.08.023_bib33) 2009; 106 Rappsilber (10.1016/j.omtn.2023.08.023_bib89) 2007; 2 Jain (10.1016/j.omtn.2023.08.023_bib84) 2010; 285 Verma (10.1016/j.omtn.2023.08.023_bib42) 2021; 11 Kim (10.1016/j.omtn.2023.08.023_bib75) 2015; 5 Xiong (10.1016/j.omtn.2023.08.023_bib85) 2014; 10 Denney (10.1016/j.omtn.2023.08.023_bib16) 2012; 189 Bauermeister (10.1016/j.omtn.2023.08.023_bib62) 1998; 13 Steinman (10.1016/j.omtn.2023.08.023_bib41) 2014; 32 Simmons (10.1016/j.omtn.2023.08.023_bib39) 2022; 7 Schneider (10.1016/j.omtn.2023.08.023_bib76) 2014; 32 Malaer (10.1016/j.omtn.2023.08.023_bib82) 2017; 7 Hofman (10.1016/j.omtn.2023.08.023_bib45) 1989; 170 Ping (10.1016/j.omtn.2023.08.023_bib60) 1996; 4 (10.1016/j.omtn.2023.08.023_bib56) 1999; 53 Beavers (10.1016/j.omtn.2023.08.023_bib21) 2015; 88 Cox (10.1016/j.omtn.2023.08.023_bib92) 2011; 10 Jiang (10.1016/j.omtn.2023.08.023_bib63) 1992; 148 Mantovani (10.1016/j.omtn.2023.08.023_bib6) 2013; 229 Shechter (10.1016/j.omtn.2023.08.023_bib18) 2013; 38 S Clemente (10.1016/j.omtn.2023.08.023_bib29) 2020; 21 Zhou (10.1016/j.omtn.2023.08.023_bib80) 2013; 9 Fransson (10.1016/j.omtn.2023.08.023_bib43) 2009; 126 Arnett (10.1016/j.omtn.2023.08.023_bib57) 2001; 4 Nahrendorf (10.1016/j.omtn.2023.08.023_bib9) 2016; 119 Murray (10.1016/j.omtn.2023.08.023_bib12) 2014; 41 Valentin-Torres (10.1016/j.omtn.2023.08.023_bib49) 2016; 13 Sonneville (10.1016/j.omtn.2023.08.023_bib26) 2017; 8 Ko (10.1016/j.omtn.2023.08.023_bib87) 2017; 8 Niespolo (10.1016/j.omtn.2023.08.023_bib22) 2020; 11 Zhong (10.1016/j.omtn.2023.08.023_bib37) 2016; 164 Korhonen (10.1016/j.omtn.2023.08.023_bib86) 2019; 116 Tyanova (10.1016/j.omtn.2023.08.023_bib96) 2016; 13 Parisi (10.1016/j.omtn.2023.08.023_bib2) 2018; 2018 Ohmori (10.1016/j.omtn.2023.08.023_bib78) 2001; 69 Peterson (10.1016/j.omtn.2023.08.023_bib4) 2018; 39 Kovarik (10.1016/j.omtn.2023.08.023_bib79) 1998; 17 Deutsch (10.1016/j.omtn.2023.08.023_bib94) 2020; 48 Huang (10.1016/j.omtn.2023.08.023_bib38) 2018; 17 Kruglov (10.1016/j.omtn.2023.08.023_bib58) 2011; 187 Dansereau (10.1016/j.omtn.2023.08.023_bib64) 2021; 18 Mahad (10.1016/j.omtn.2023.08.023_bib71) 2003; 15 Schraufstatter (10.1016/j.omtn.2023.08.023_bib73) 2012; 135 Sergin (10.1016/j.omtn.2023.08.023_bib88) 2016; 9 Selmaj (10.1016/j.omtn.2023.08.023_bib46) 1991; 87 Self-Fordham (10.1016/j.omtn.2023.08.023_bib19) 2017; 8 Dowling (10.1016/j.omtn.2023.08.023_bib30) 2021; 12 Al-Haidari (10.1016/j.omtn.2023.08.023_bib54) 2018; 421 Hutchins (10.1016/j.omtn.2023.08.023_bib35) 2013; 12 Wang (10.1016/j.omtn.2023.08.023_bib34) 2010; 185 Kodelja (10.1016/j.omtn.2023.08.023_bib74) 1998; 160 Simpson (10.1016/j.omtn.2023.08.023_bib69) 1998; 84 Perez-Riverol (10.1016/j.omtn.2023.08.023_bib95) 2022; 50 McCarthy (10.1016/j.omtn.2023.08.023_bib14) 2013; 27 Ponzoni (10.1016/j.omtn.2023.08.023_bib5) 2018; 19 Teng (10.1016/j.omtn.2023.08.023_bib67) 2017; 16 Dogan (10.1016/j.omtn.2023.08.023_bib66) 2008; 180 Schett (10.1016/j.omtn.2023.08.023_bib7) 2018; 9 Iarlori (10.1016/j.omtn.2023.08.023_bib72) 2002; 123 Wang (10.1016/j.omtn.2023.08.023_bib20) 2014; 5 Raggi (10.1016/j.omtn.2023.08.023_bib11) 2017; 8 Li (10.1016/j.omtn.2023.08.023_bib68) 2017; 66 Fresegna (10.1016/j.omtn.2023.08.023_bib47) 2020; 9 Xia (10.1016/j.omtn.2023.08.023_bib83) 2018; 10 Unuvar Purcu (10.1016/j.omtn.2023.08.023_bib13) 2022; 17 De Santi (10.1016/j.omtn.2023.08.023_bib27) 2020; 28 Trapp (10.1016/j.omtn.2023.08.023_bib40) 2008; 31 Chu (10.1016/j.omtn.2023.08.023_bib3) 2018; 318 Hardbower (10.1016/j.omtn.2023.08.023_bib50) 2016; 48 Wei (10.1016/j.omtn.2023.08.023_bib23) 2018; 138 Acquaviva (10.1016/j.omtn.2023.08.023_bib44) 2020; 1 Schultze (10.1016/j.omtn.2023.08.023_bib1) 2015; 27 Mills (10.1016/j.omtn.2023.08.023_bib8) 2000; 164 Ping (10.1016/j.omtn.2023.08.023_bib61) 2000; 275 Fioranelli (10.1016/j.omtn.2023.08.023_bib32) 2014; 1 Bi (10.1016/j.omtn.2023.08.023_bib15) 2019; 2019 Lawrence (10.1016/j.omtn.2023.08.023_bib77) 2011; 11 |
References_xml | – volume: 8 start-page: 40817 year: 2017 end-page: 40831 ident: bib87 article-title: Rapamycin regulates macrophage activation by inhibiting NLRP3 inflammasome-p38 MAPK-NFκB pathways in autophagy- and p62-dependent manners publication-title: Oncotarget contributor: fullname: Oh – volume: 119 start-page: 414 year: 2016 end-page: 417 ident: bib9 article-title: Abandoning M1/M2 for a Network Model of Macrophage Function publication-title: Circ. Res. contributor: fullname: Swirski – volume: 123 start-page: 170 year: 2002 end-page: 179 ident: bib72 article-title: Interferon β-1b modulates MCP-1 expression and production in relapsing–remitting multiple sclerosis publication-title: J. Neuroimmunol. contributor: fullname: Lugaresi – volume: 86 start-page: 20 year: 1998 end-page: 29 ident: bib70 article-title: MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and publication-title: J. Neuroimmunol. contributor: fullname: Brosnan – volume: 17 start-page: e0265196 year: 2022 ident: bib13 article-title: Effect of stimulation time on the expression of human macrophage polarization markers publication-title: PLoS One contributor: fullname: Sag – volume: 10 start-page: 1324 year: 2018 end-page: 1337 ident: bib83 article-title: Integrated DNA methylation and gene expression analysis identifies SLAMF7 as a key regulator of atherosclerosis publication-title: Aging (Albany NY) contributor: fullname: Wang – volume: 38 start-page: 555 year: 2013 end-page: 569 ident: bib18 article-title: Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus publication-title: Immunity contributor: fullname: Bendel – volume: 1 start-page: 2 year: 2014 end-page: 6 ident: bib32 article-title: Twenty-five years of studies and trials for the therapeutic application of IL-10 immunomodulating properties. From high doses administration to low dose medicine new paradigm publication-title: J Integr Cardiol contributor: fullname: Roccia – volume: 185 start-page: 6226 year: 2010 end-page: 6233 ident: bib34 article-title: Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1 publication-title: J. Immunol. contributor: fullname: Cao – volume: 54 start-page: 2950 year: 2017 end-page: 2960 ident: bib48 article-title: Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability publication-title: Mol. Neurobiol. contributor: fullname: Kaimen-Maciel – volume: 13 start-page: 2513 year: 2014 end-page: 2526 ident: bib93 article-title: Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ publication-title: Mol. Cell. Proteomics contributor: fullname: Mann – volume: 39 start-page: 536 year: 2018 end-page: 546 ident: bib4 article-title: Macrophage-Targeted Therapeutics for Metabolic Disease publication-title: Trends Pharmacol. Sci. contributor: fullname: Hasty – volume: 29 start-page: 13435 year: 2009 end-page: 13444 ident: bib17 article-title: Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord publication-title: J. Neurosci. contributor: fullname: Popovich – volume: 32 start-page: 257 year: 2014 end-page: 281 ident: bib41 article-title: Immunology of relapse and remission in multiple sclerosis publication-title: Annu. Rev. Immunol. contributor: fullname: Steinman – volume: 148 start-page: 2423 year: 1992 end-page: 2428 ident: bib63 article-title: Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes publication-title: J. Immunol. contributor: fullname: Graves – volume: 69 start-page: 598 year: 2001 end-page: 604 ident: bib78 article-title: Requirement for STAT1 in LPS-induced gene expression in macrophages publication-title: J. Leukoc. Biol. contributor: fullname: Hamilton – volume: 21 start-page: 5291 year: 2020 ident: bib29 article-title: Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective publication-title: Int. J. Mol. Sci. contributor: fullname: H Elsinga – volume: 16 start-page: 312 year: 2017 end-page: 322 ident: bib67 article-title: Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model publication-title: Mol. Cancer Therapeut. contributor: fullname: Caligiuri – volume: 9 start-page: ra2 year: 2016 ident: bib88 article-title: Inclusion bodies enriched for p62 and polyubiquitinated proteins in macrophages protect against atherosclerosis publication-title: Sci. Signal. contributor: fullname: Razani – volume: 48 start-page: 2375 year: 2016 end-page: 2388 ident: bib50 article-title: Arginase 2 deletion leads to enhanced M1 macrophage activation and upregulated polyamine metabolism in response to Helicobacter pylori infection publication-title: Amino Acids contributor: fullname: Wilson – volume: 2019 start-page: 6724903 year: 2019 ident: bib15 article-title: M2 Macrophages as a Potential Target for Antiatherosclerosis Treatment publication-title: Neural Plast. contributor: fullname: Zhao – volume: 12 start-page: 1460 year: 2021 ident: bib30 article-title: Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages publication-title: Nat. Commun. contributor: fullname: Gough – volume: 10 start-page: 2759 year: 2019 ident: bib59 article-title: More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis publication-title: Front. Immunol. contributor: fullname: Midwood – volume: 41 start-page: 14 year: 2014 end-page: 20 ident: bib12 article-title: Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines publication-title: Immunity contributor: fullname: Lawrence – volume: 15 start-page: 23 year: 2003 end-page: 32 ident: bib71 article-title: The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE) publication-title: Semin. Immunol. contributor: fullname: Ransohoff – volume: 164 start-page: 896 year: 2016 end-page: 910 ident: bib37 article-title: NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria publication-title: Cell contributor: fullname: Ali – volume: 170 start-page: 607 year: 1989 end-page: 612 ident: bib45 article-title: Tumor necrosis factor identified in multiple sclerosis brain publication-title: J. Exp. Med. contributor: fullname: Merrill – volume: 7 start-page: eabf2846 year: 2022 ident: bib39 article-title: SLAMF7 engagement superactivates macrophages in acute and chronic inflammation publication-title: Sci. Immunol. contributor: fullname: Earp – volume: 1 start-page: 100053 year: 2020 ident: bib44 article-title: Inferring Multiple Sclerosis Stages from the Blood Transcriptome via Machine Learning publication-title: Cell Rep. Med. contributor: fullname: Farina – volume: 87 start-page: 949 year: 1991 end-page: 954 ident: bib46 article-title: Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions publication-title: J. Clin. Invest. contributor: fullname: Brosnan – volume: 116 start-page: 70 year: 2019 end-page: 77 ident: bib86 article-title: SQSTM1/p62 regulates the production of IL-8 and MCP-1 in IL-1β-stimulated human retinal pigment epithelial cells publication-title: Cytokine contributor: fullname: Kauppinen – volume: 187 start-page: 5660 year: 2011 end-page: 5670 ident: bib58 article-title: Pathogenic and Protective Functions of TNF in Neuroinflammation Are Defined by Its Expression in T Lymphocytes and Myeloid Cells publication-title: J. Immunol. contributor: fullname: Nedospasov – volume: 9 start-page: 302 year: 2020 ident: bib51 article-title: Arginase 2 Deficiency Promotes Neuroinflammation and Pain Behaviors Following Nerve Injury in Mice publication-title: J. Clin. Med. contributor: fullname: Hong – volume: 31 start-page: 247 year: 2008 end-page: 269 ident: bib40 article-title: Multiple sclerosis: an immune or neurodegenerative disorder? publication-title: Annu. Rev. Neurosci. contributor: fullname: Nave – volume: 421 start-page: 145 year: 2018 end-page: 151 ident: bib54 article-title: MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R (HuR) publication-title: Cancer Lett. contributor: fullname: Thorlacius – volume: 187 start-page: 2559 year: 2011 end-page: 2568 ident: bib81 article-title: IFN-Induced TPR Protein IFIT3 Potentiates Antiviral Signaling by Bridging MAVS and TBK1 publication-title: J. Immunol. contributor: fullname: Wang – volume: 18 start-page: 79 year: 2021 ident: bib64 article-title: Mechanistic insights into the role of the chemokine CCL2/CCR2 axis in dorsal root ganglia to peripheral inflammation and pain hypersensitivity publication-title: J. Neuroinflammation contributor: fullname: Sarret – volume: 88 start-page: 123 year: 2015 end-page: 137 ident: bib21 article-title: MiRNA inhibition in tissue engineering and regenerative medicine publication-title: Adv. Drug Deliv. Rev. contributor: fullname: Duvall – volume: 9 start-page: 2645 year: 2018 ident: bib28 article-title: miR-103 promotes endothelial maladaptation by targeting lncWDR59 publication-title: Nat. Commun. contributor: fullname: Schober – volume: 13 start-page: 731 year: 2016 end-page: 740 ident: bib96 article-title: The Perseus computational platform for comprehensive analysis of (prote)omics data publication-title: Nat. Methods contributor: fullname: Cox – volume: 66 start-page: 157 year: 2017 end-page: 167 ident: bib68 article-title: Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma publication-title: Gut contributor: fullname: Wang – volume: 9 start-page: 3261 year: 2018 ident: bib7 article-title: Resolution of chronic inflammatory disease: universal and tissue-specific concepts publication-title: Nat. Commun. contributor: fullname: Neurath – volume: 13 start-page: 46 year: 2016 ident: bib49 article-title: Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis publication-title: J. Neuroinflammation contributor: fullname: Stohlman – volume: 189 start-page: 551 year: 2012 end-page: 557 ident: bib16 article-title: Activation of Invariant NKT Cells in Early Phase of Experimental Autoimmune Encephalomyelitis Results in Differentiation of Ly6Chi Inflammatory Monocyte to M2 Macrophages and Improved Outcome publication-title: J. Immunol. contributor: fullname: Ho – volume: 8 start-page: 1097 year: 2017 ident: bib11 article-title: Regulation of Human Macrophage M1–M2 Polarization Balance by Hypoxia and the Triggering Receptor Expressed on Myeloid Cells-1 publication-title: Front. Immunol. contributor: fullname: Bosco – volume: 48 start-page: D1145 year: 2020 end-page: D1152 ident: bib94 article-title: The ProteomeXchange consortium in 2020: enabling 'big data' approaches in proteomics publication-title: Nucleic Acids Res. contributor: fullname: Pullman – volume: 11 start-page: 574046 year: 2020 ident: bib22 article-title: Tribbles-1 Expression and Its Function to Control Inflammatory Cytokines, Including Interleukin-8 Levels are Regulated by miRNAs in Macrophages and Prostate Cancer Cells publication-title: Front. Immunol. contributor: fullname: Kiss-Toth – volume: 122 start-page: 2911 year: 2013 end-page: 2919 ident: bib25 article-title: Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27 publication-title: Blood contributor: fullname: Ng – volume: 12 start-page: 49 year: 2016 end-page: 62 ident: bib55 article-title: TNF biology, pathogenic mechanisms and emerging therapeutic strategies publication-title: Nat. Rev. Rheumatol. contributor: fullname: Ivashkiv – volume: 17 start-page: 3660 year: 1998 end-page: 3668 ident: bib79 article-title: Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation publication-title: EMBO J. contributor: fullname: Decker – volume: 2 start-page: 1896 year: 2007 end-page: 1906 ident: bib89 article-title: Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips publication-title: Nat. Protoc. contributor: fullname: Ishihama – volume: 8 start-page: 14887 year: 2017 end-page: 14896 ident: bib53 article-title: MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoA publication-title: Oncotarget contributor: fullname: Thorlacius – volume: 11 start-page: 2301 year: 2016 end-page: 2319 ident: bib91 article-title: The MaxQuant computational platform for mass spectrometry-based shotgun proteomics publication-title: Nat. Protoc. contributor: fullname: Cox – volume: 11 start-page: 576516 year: 2020 ident: bib10 article-title: microRNA-155 Is Decreased During Atherosclerosis Regression and Is Increased in Urinary Extracellular Vesicles During Atherosclerosis Progression publication-title: Front. Immunol. contributor: fullname: Belton – volume: 135 start-page: 287 year: 2012 end-page: 298 ident: bib73 article-title: The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum publication-title: Immunology contributor: fullname: Discipio – volume: 106 start-page: 7113 year: 2009 end-page: 7118 ident: bib33 article-title: Inositol phosphatase SHIP1 is a primary target of miR-155 publication-title: Proc. Natl. Acad. Sci. USA contributor: fullname: Baltimore – volume: 193 start-page: 713 year: 2001 end-page: 726 ident: bib65 article-title: Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis publication-title: J. Exp. Med. contributor: fullname: Ransohoff – volume: 26 start-page: 1367 year: 2008 end-page: 1372 ident: bib90 article-title: MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification publication-title: Nat. Biotechnol. contributor: fullname: Mann – volume: 229 start-page: 176 year: 2013 end-page: 185 ident: bib6 article-title: Macrophage plasticity and polarization in tissue repair and remodelling publication-title: J. Pathol. contributor: fullname: Locati – volume: 5 start-page: 614 year: 2014 ident: bib20 article-title: Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance publication-title: Front. Immunol. contributor: fullname: Zen – volume: 119 start-page: 9419 year: 2018 end-page: 9432 ident: bib36 article-title: IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma publication-title: J. Cell. Biochem. contributor: fullname: Jian – volume: 11 start-page: 750 year: 2011 end-page: 761 ident: bib77 article-title: Transcriptional regulation of macrophage polarization: enabling diversity with identity publication-title: Nat. Rev. Immunol. contributor: fullname: Natoli – volume: 4 start-page: 455 year: 1996 end-page: 469 ident: bib60 article-title: TNF regulates the publication-title: Immunity contributor: fullname: Boss – volume: 2018 start-page: 8917804 year: 2018 ident: bib2 article-title: Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders? publication-title: J. Immunol. Res. contributor: fullname: Mortara – volume: 10 start-page: 1794 year: 2011 end-page: 1805 ident: bib92 article-title: Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment publication-title: J. Proteome Res. contributor: fullname: Mann – volume: 8 start-page: 1062 year: 2017 ident: bib19 article-title: MicroRNA: Dynamic Regulators of Macrophage Polarization and Plasticity publication-title: Front. Immunol. contributor: fullname: Nares – volume: 28 start-page: 1190 year: 2020 end-page: 1199 ident: bib27 article-title: Precise Targeting of miRNA Sites Restores CFTR Activity in CF Bronchial Epithelial Cells publication-title: Mol. Ther. contributor: fullname: Mu – volume: 11 start-page: 10476 year: 2021 ident: bib42 article-title: Multiple sclerosis patients have reduced resting and increased activated CD4+CD25+FOXP3+T regulatory cells publication-title: Sci. Rep. contributor: fullname: Hodgkinson – volume: 160 start-page: 1411 year: 1998 end-page: 1418 ident: bib74 article-title: Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern publication-title: J. Immunol. contributor: fullname: Goerdt – volume: 275 start-page: 1708 year: 2000 end-page: 1714 ident: bib61 article-title: Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene by tumor necrosis factor publication-title: J. Biol. Chem. contributor: fullname: Boss – volume: 9 start-page: 200 year: 2013 end-page: 208 ident: bib80 article-title: Interferon induced IFIT family genes in host antiviral defense publication-title: Int. J. Biol. Sci. contributor: fullname: Jiang – volume: 10 start-page: 2223 year: 2014 end-page: 2238 ident: bib85 article-title: ARG2 impairs endothelial autophagy through regulation of MTOR and PRKAA/AMPK signaling in advanced atherosclerosis publication-title: Autophagy contributor: fullname: Ming – volume: 29 start-page: 643 year: 2022 end-page: 655 ident: bib31 article-title: Enhancing arginase 2 expression using target site blockers as a strategy to modulate macrophage phenotype publication-title: Mol. Ther. Nucleic Acids contributor: fullname: McCoy – volume: 126 start-page: 92 year: 2009 end-page: 101 ident: bib43 article-title: The T-cell pool is anergized in patients with multiple sclerosis in remission publication-title: Immunology contributor: fullname: Loskog – volume: 84 start-page: 238 year: 1998 end-page: 249 ident: bib69 article-title: Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions publication-title: J. Neuroimmunol. contributor: fullname: Woodroofe – volume: 7 start-page: 1637 year: 2017 end-page: 1641 ident: bib82 article-title: CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma publication-title: Am J Cancer Rs contributor: fullname: Mathew – volume: 281 start-page: 32197 year: 2006 end-page: 32206 ident: bib52 article-title: The Arginase II Gene Is an Anti-inflammatory Target of Liver X Receptor in Macrophages publication-title: J. Biol. Chem. contributor: fullname: Castrillo – volume: 5 start-page: 13414 year: 2015 ident: bib75 article-title: STAT1 deficiency redirects IFN signalling toward suppression of TLR response through a feedback activation of STAT3 publication-title: Sci. Rep. contributor: fullname: Choi – volume: 7 start-page: 10521 year: 2016 ident: bib24 article-title: Endothelial Dicer promotes atherosclerosis and vascular inflammation by miRNA-103-mediated suppression of KLF4 publication-title: Nat. Commun. contributor: fullname: Schober – volume: 9 start-page: 2290 year: 2020 ident: bib47 article-title: Re-Examining the Role of TNF in MS Pathogenesis and Therapy publication-title: Cells contributor: fullname: Dolcetti – volume: 13 start-page: 1412 year: 1998 end-page: 1419 ident: bib62 article-title: Distinct regulation of IL-8 and MCP-1 by LPS and interferon-gamma-treated human peritoneal macrophages publication-title: Nephrol. Dial. Transplant. contributor: fullname: Dobos – volume: 19 start-page: 1953 year: 2018 ident: bib5 article-title: Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer publication-title: Int. J. Mol. Sci. contributor: fullname: Brignole – volume: 318 start-page: 1 year: 2018 end-page: 7 ident: bib3 article-title: The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis publication-title: J. Neuroimmunol. contributor: fullname: Cui – volume: 32 start-page: 513 year: 2014 end-page: 545 ident: bib76 article-title: Interferon-stimulated genes: a complex web of host defenses publication-title: Annu. Rev. Immunol. contributor: fullname: Rice – volume: 4 start-page: 1116 year: 2001 end-page: 1122 ident: bib57 article-title: TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination publication-title: Nat. Neurosci. contributor: fullname: Ting – volume: 27 start-page: 249 year: 2015 end-page: 256 ident: bib1 article-title: Macrophage activation in human diseases publication-title: Semin. Immunol. contributor: fullname: Goerdt – volume: 17 start-page: 1485 year: 2018 end-page: 1499 ident: bib38 article-title: Proteomic Identification of Interferon-Induced Proteins with Tetratricopeptide Repeats as Markers of M1 Macrophage Polarization publication-title: J. Proteome Res. contributor: fullname: Zhu – volume: 53 start-page: 457 year: 1999 end-page: 465 ident: bib56 article-title: TNF neutralization in MS publication-title: Neurology – volume: 27 start-page: 499 year: 2013 end-page: 510 ident: bib14 article-title: IL-10 mediates the immunoregulatory response in conjugated linoleic acid-induced regression of atherosclerosis publication-title: Faseb. J. contributor: fullname: Belton – volume: 138 start-page: 2007 year: 2018 end-page: 2020 ident: bib23 article-title: Dicer in Macrophages Prevents Atherosclerosis by Promoting Mitochondrial Oxidative Metabolism publication-title: Circulation contributor: fullname: Uhlenhaut – volume: 180 start-page: 7376 year: 2008 end-page: 7384 ident: bib66 article-title: Production of CCL2 by Central Nervous System Cells Regulates Development of Murine Experimental Autoimmune Encephalomyelitis through the Recruitment of TNF- and iNOS-Expressing Macrophages and Myeloid Dendritic Cells publication-title: J. Immunol. contributor: fullname: Karpus – volume: 8 start-page: 710 year: 2017 ident: bib26 article-title: MicroRNA-9 downregulates the ANO1 chloride channel and contributes to cystic fibrosis lung pathology publication-title: Nat. Commun. contributor: fullname: Tabary – volume: 164 start-page: 6166 year: 2000 end-page: 6173 ident: bib8 article-title: M-1/M-2 Macrophages and the Th1/Th2 Paradigm publication-title: J. Immunol. contributor: fullname: Hill – volume: 12 start-page: 489 year: 2013 end-page: 498 ident: bib35 article-title: The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges publication-title: Brief. Funct. Genomics contributor: fullname: Miranda-Saavedra – volume: 285 start-page: 22576 year: 2010 end-page: 22591 ident: bib84 article-title: p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription publication-title: J. Biol. Chem. contributor: fullname: Johansen – volume: 50 start-page: D543 year: 2022 end-page: D552 ident: bib95 article-title: The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences publication-title: Nucleic Acids Res. contributor: fullname: Eisenacher – volume: 275 start-page: 1708 year: 2000 ident: 10.1016/j.omtn.2023.08.023_bib61 article-title: Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene by tumor necrosis factor publication-title: J. Biol. Chem. doi: 10.1074/jbc.275.3.1708 contributor: fullname: Ping – volume: 160 start-page: 1411 year: 1998 ident: 10.1016/j.omtn.2023.08.023_bib74 article-title: Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern publication-title: J. Immunol. doi: 10.4049/jimmunol.160.3.1411 contributor: fullname: Kodelja – volume: 87 start-page: 949 year: 1991 ident: 10.1016/j.omtn.2023.08.023_bib46 article-title: Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions publication-title: J. Clin. Invest. doi: 10.1172/JCI115102 contributor: fullname: Selmaj – volume: 53 start-page: 457 year: 1999 ident: 10.1016/j.omtn.2023.08.023_bib56 article-title: TNF neutralization in MS publication-title: Neurology doi: 10.1212/WNL.53.3.457 – volume: 13 start-page: 46 year: 2016 ident: 10.1016/j.omtn.2023.08.023_bib49 article-title: Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis publication-title: J. Neuroinflammation doi: 10.1186/s12974-016-0513-y contributor: fullname: Valentin-Torres – volume: 119 start-page: 9419 year: 2018 ident: 10.1016/j.omtn.2023.08.023_bib36 article-title: IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma publication-title: J. Cell. Biochem. doi: 10.1002/jcb.27259 contributor: fullname: Yin – volume: 193 start-page: 713 year: 2001 ident: 10.1016/j.omtn.2023.08.023_bib65 article-title: Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis publication-title: J. Exp. Med. doi: 10.1084/jem.193.6.713 contributor: fullname: Huang – volume: 8 start-page: 1097 year: 2017 ident: 10.1016/j.omtn.2023.08.023_bib11 article-title: Regulation of Human Macrophage M1–M2 Polarization Balance by Hypoxia and the Triggering Receptor Expressed on Myeloid Cells-1 publication-title: Front. Immunol. doi: 10.3389/fimmu.2017.01097 contributor: fullname: Raggi – volume: 29 start-page: 13435 year: 2009 ident: 10.1016/j.omtn.2023.08.023_bib17 article-title: Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.3257-09.2009 contributor: fullname: Kigerl – volume: 18 start-page: 79 year: 2021 ident: 10.1016/j.omtn.2023.08.023_bib64 article-title: Mechanistic insights into the role of the chemokine CCL2/CCR2 axis in dorsal root ganglia to peripheral inflammation and pain hypersensitivity publication-title: J. Neuroinflammation doi: 10.1186/s12974-021-02125-y contributor: fullname: Dansereau – volume: 9 start-page: 302 year: 2020 ident: 10.1016/j.omtn.2023.08.023_bib51 article-title: Arginase 2 Deficiency Promotes Neuroinflammation and Pain Behaviors Following Nerve Injury in Mice publication-title: J. Clin. Med. contributor: fullname: Yin – volume: 2 start-page: 1896 year: 2007 ident: 10.1016/j.omtn.2023.08.023_bib89 article-title: Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips publication-title: Nat. Protoc. doi: 10.1038/nprot.2007.261 contributor: fullname: Rappsilber – volume: 26 start-page: 1367 year: 2008 ident: 10.1016/j.omtn.2023.08.023_bib90 article-title: MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification publication-title: Nat. Biotechnol. doi: 10.1038/nbt.1511 contributor: fullname: Cox – volume: 19 start-page: 1953 year: 2018 ident: 10.1016/j.omtn.2023.08.023_bib5 article-title: Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms19071953 contributor: fullname: Ponzoni – volume: 135 start-page: 287 year: 2012 ident: 10.1016/j.omtn.2023.08.023_bib73 article-title: The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum publication-title: Immunology doi: 10.1111/j.1365-2567.2011.03541.x contributor: fullname: Schraufstatter – volume: 7 start-page: 1637 year: 2017 ident: 10.1016/j.omtn.2023.08.023_bib82 article-title: CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma publication-title: Am J Cancer Rs contributor: fullname: Malaer – volume: 138 start-page: 2007 year: 2018 ident: 10.1016/j.omtn.2023.08.023_bib23 article-title: Dicer in Macrophages Prevents Atherosclerosis by Promoting Mitochondrial Oxidative Metabolism publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.117.031589 contributor: fullname: Wei – volume: 116 start-page: 70 year: 2019 ident: 10.1016/j.omtn.2023.08.023_bib86 article-title: SQSTM1/p62 regulates the production of IL-8 and MCP-1 in IL-1β-stimulated human retinal pigment epithelial cells publication-title: Cytokine doi: 10.1016/j.cyto.2018.12.015 contributor: fullname: Korhonen – volume: 50 start-page: D543 year: 2022 ident: 10.1016/j.omtn.2023.08.023_bib95 article-title: The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkab1038 contributor: fullname: Perez-Riverol – volume: 9 start-page: 3261 year: 2018 ident: 10.1016/j.omtn.2023.08.023_bib7 article-title: Resolution of chronic inflammatory disease: universal and tissue-specific concepts publication-title: Nat. Commun. doi: 10.1038/s41467-018-05800-6 contributor: fullname: Schett – volume: 126 start-page: 92 year: 2009 ident: 10.1016/j.omtn.2023.08.023_bib43 article-title: The T-cell pool is anergized in patients with multiple sclerosis in remission publication-title: Immunology doi: 10.1111/j.1365-2567.2008.02881.x contributor: fullname: Fransson – volume: 189 start-page: 551 year: 2012 ident: 10.1016/j.omtn.2023.08.023_bib16 article-title: Activation of Invariant NKT Cells in Early Phase of Experimental Autoimmune Encephalomyelitis Results in Differentiation of Ly6Chi Inflammatory Monocyte to M2 Macrophages and Improved Outcome publication-title: J. Immunol. doi: 10.4049/jimmunol.1103608 contributor: fullname: Denney – volume: 66 start-page: 157 year: 2017 ident: 10.1016/j.omtn.2023.08.023_bib68 article-title: Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma publication-title: Gut doi: 10.1136/gutjnl-2015-310514 contributor: fullname: Li – volume: 69 start-page: 598 year: 2001 ident: 10.1016/j.omtn.2023.08.023_bib78 article-title: Requirement for STAT1 in LPS-induced gene expression in macrophages publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.69.4.598 contributor: fullname: Ohmori – volume: 21 start-page: 5291 year: 2020 ident: 10.1016/j.omtn.2023.08.023_bib29 article-title: Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21155291 contributor: fullname: S Clemente – volume: 16 start-page: 312 year: 2017 ident: 10.1016/j.omtn.2023.08.023_bib67 article-title: Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model publication-title: Mol. Cancer Therapeut. doi: 10.1158/1535-7163.MCT-16-0124 contributor: fullname: Teng – volume: 32 start-page: 513 year: 2014 ident: 10.1016/j.omtn.2023.08.023_bib76 article-title: Interferon-stimulated genes: a complex web of host defenses publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev-immunol-032713-120231 contributor: fullname: Schneider – volume: 8 start-page: 40817 year: 2017 ident: 10.1016/j.omtn.2023.08.023_bib87 article-title: Rapamycin regulates macrophage activation by inhibiting NLRP3 inflammasome-p38 MAPK-NFκB pathways in autophagy- and p62-dependent manners publication-title: Oncotarget doi: 10.18632/oncotarget.17256 contributor: fullname: Ko – volume: 164 start-page: 896 year: 2016 ident: 10.1016/j.omtn.2023.08.023_bib37 article-title: NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria publication-title: Cell doi: 10.1016/j.cell.2015.12.057 contributor: fullname: Zhong – volume: 13 start-page: 731 year: 2016 ident: 10.1016/j.omtn.2023.08.023_bib96 article-title: The Perseus computational platform for comprehensive analysis of (prote)omics data publication-title: Nat. Methods doi: 10.1038/nmeth.3901 contributor: fullname: Tyanova – volume: 11 start-page: 576516 year: 2020 ident: 10.1016/j.omtn.2023.08.023_bib10 article-title: microRNA-155 Is Decreased During Atherosclerosis Regression and Is Increased in Urinary Extracellular Vesicles During Atherosclerosis Progression publication-title: Front. Immunol. doi: 10.3389/fimmu.2020.576516 contributor: fullname: Fitzsimons – volume: 86 start-page: 20 year: 1998 ident: 10.1016/j.omtn.2023.08.023_bib70 article-title: MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study publication-title: J. Neuroimmunol. doi: 10.1016/S0165-5728(98)00002-2 contributor: fullname: McManus – volume: 281 start-page: 32197 year: 2006 ident: 10.1016/j.omtn.2023.08.023_bib52 article-title: The Arginase II Gene Is an Anti-inflammatory Target of Liver X Receptor in Macrophages publication-title: J. Biol. Chem. doi: 10.1074/jbc.M605237200 contributor: fullname: Marathe – volume: 421 start-page: 145 year: 2018 ident: 10.1016/j.omtn.2023.08.023_bib54 article-title: MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R (HuR) publication-title: Cancer Lett. doi: 10.1016/j.canlet.2018.02.026 contributor: fullname: Al-Haidari – volume: 13 start-page: 1412 year: 1998 ident: 10.1016/j.omtn.2023.08.023_bib62 article-title: Distinct regulation of IL-8 and MCP-1 by LPS and interferon-gamma-treated human peritoneal macrophages publication-title: Nephrol. Dial. Transplant. doi: 10.1093/ndt/13.6.1412 contributor: fullname: Bauermeister – volume: 12 start-page: 1460 year: 2021 ident: 10.1016/j.omtn.2023.08.023_bib30 article-title: Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages publication-title: Nat. Commun. doi: 10.1038/s41467-021-21617-2 contributor: fullname: Dowling – volume: 31 start-page: 247 year: 2008 ident: 10.1016/j.omtn.2023.08.023_bib40 article-title: Multiple sclerosis: an immune or neurodegenerative disorder? publication-title: Annu. Rev. Neurosci. doi: 10.1146/annurev.neuro.30.051606.094313 contributor: fullname: Trapp – volume: 9 start-page: 200 year: 2013 ident: 10.1016/j.omtn.2023.08.023_bib80 article-title: Interferon induced IFIT family genes in host antiviral defense publication-title: Int. J. Biol. Sci. doi: 10.7150/ijbs.5613 contributor: fullname: Zhou – volume: 12 start-page: 49 year: 2016 ident: 10.1016/j.omtn.2023.08.023_bib55 article-title: TNF biology, pathogenic mechanisms and emerging therapeutic strategies publication-title: Nat. Rev. Rheumatol. doi: 10.1038/nrrheum.2015.169 contributor: fullname: Kalliolias – volume: 10 start-page: 1324 year: 2018 ident: 10.1016/j.omtn.2023.08.023_bib83 article-title: Integrated DNA methylation and gene expression analysis identifies SLAMF7 as a key regulator of atherosclerosis publication-title: Aging (Albany NY) doi: 10.18632/aging.101470 contributor: fullname: Xia – volume: 318 start-page: 1 year: 2018 ident: 10.1016/j.omtn.2023.08.023_bib3 article-title: The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis publication-title: J. Neuroimmunol. doi: 10.1016/j.jneuroim.2018.02.015 contributor: fullname: Chu – volume: 229 start-page: 176 year: 2013 ident: 10.1016/j.omtn.2023.08.023_bib6 article-title: Macrophage plasticity and polarization in tissue repair and remodelling publication-title: J. Pathol. doi: 10.1002/path.4133 contributor: fullname: Mantovani – volume: 180 start-page: 7376 year: 2008 ident: 10.1016/j.omtn.2023.08.023_bib66 article-title: Production of CCL2 by Central Nervous System Cells Regulates Development of Murine Experimental Autoimmune Encephalomyelitis through the Recruitment of TNF- and iNOS-Expressing Macrophages and Myeloid Dendritic Cells publication-title: J. Immunol. doi: 10.4049/jimmunol.180.11.7376 contributor: fullname: Dogan – volume: 17 start-page: 3660 year: 1998 ident: 10.1016/j.omtn.2023.08.023_bib79 article-title: Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation publication-title: EMBO J. doi: 10.1093/emboj/17.13.3660 contributor: fullname: Kovarik – volume: 15 start-page: 23 year: 2003 ident: 10.1016/j.omtn.2023.08.023_bib71 article-title: The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE) publication-title: Semin. Immunol. doi: 10.1016/S1044-5323(02)00125-2 contributor: fullname: Mahad – volume: 119 start-page: 414 year: 2016 ident: 10.1016/j.omtn.2023.08.023_bib9 article-title: Abandoning M1/M2 for a Network Model of Macrophage Function publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.116.309194 contributor: fullname: Nahrendorf – volume: 12 start-page: 489 year: 2013 ident: 10.1016/j.omtn.2023.08.023_bib35 article-title: The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges publication-title: Brief. Funct. Genomics doi: 10.1093/bfgp/elt028 contributor: fullname: Hutchins – volume: 38 start-page: 555 year: 2013 ident: 10.1016/j.omtn.2023.08.023_bib18 article-title: Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus publication-title: Immunity doi: 10.1016/j.immuni.2013.02.012 contributor: fullname: Shechter – volume: 11 start-page: 2301 year: 2016 ident: 10.1016/j.omtn.2023.08.023_bib91 article-title: The MaxQuant computational platform for mass spectrometry-based shotgun proteomics publication-title: Nat. Protoc. doi: 10.1038/nprot.2016.136 contributor: fullname: Tyanova – volume: 187 start-page: 5660 year: 2011 ident: 10.1016/j.omtn.2023.08.023_bib58 article-title: Pathogenic and Protective Functions of TNF in Neuroinflammation Are Defined by Its Expression in T Lymphocytes and Myeloid Cells publication-title: J. Immunol. doi: 10.4049/jimmunol.1100663 contributor: fullname: Kruglov – volume: 148 start-page: 2423 year: 1992 ident: 10.1016/j.omtn.2023.08.023_bib63 article-title: Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes publication-title: J. Immunol. doi: 10.4049/jimmunol.148.8.2423 contributor: fullname: Jiang – volume: 27 start-page: 249 year: 2015 ident: 10.1016/j.omtn.2023.08.023_bib1 article-title: Macrophage activation in human diseases publication-title: Semin. Immunol. doi: 10.1016/j.smim.2015.07.003 contributor: fullname: Schultze – volume: 54 start-page: 2950 year: 2017 ident: 10.1016/j.omtn.2023.08.023_bib48 article-title: Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability publication-title: Mol. Neurobiol. doi: 10.1007/s12035-016-9846-x contributor: fullname: Kallaur – volume: 48 start-page: D1145 year: 2020 ident: 10.1016/j.omtn.2023.08.023_bib94 article-title: The ProteomeXchange consortium in 2020: enabling 'big data' approaches in proteomics publication-title: Nucleic Acids Res. contributor: fullname: Deutsch – volume: 11 start-page: 574046 year: 2020 ident: 10.1016/j.omtn.2023.08.023_bib22 article-title: Tribbles-1 Expression and Its Function to Control Inflammatory Cytokines, Including Interleukin-8 Levels are Regulated by miRNAs in Macrophages and Prostate Cancer Cells publication-title: Front. Immunol. doi: 10.3389/fimmu.2020.574046 contributor: fullname: Niespolo – volume: 48 start-page: 2375 year: 2016 ident: 10.1016/j.omtn.2023.08.023_bib50 article-title: Arginase 2 deletion leads to enhanced M1 macrophage activation and upregulated polyamine metabolism in response to Helicobacter pylori infection publication-title: Amino Acids doi: 10.1007/s00726-016-2231-2 contributor: fullname: Hardbower – volume: 8 start-page: 710 year: 2017 ident: 10.1016/j.omtn.2023.08.023_bib26 article-title: MicroRNA-9 downregulates the ANO1 chloride channel and contributes to cystic fibrosis lung pathology publication-title: Nat. Commun. doi: 10.1038/s41467-017-00813-z contributor: fullname: Sonneville – volume: 5 start-page: 13414 year: 2015 ident: 10.1016/j.omtn.2023.08.023_bib75 article-title: STAT1 deficiency redirects IFN signalling toward suppression of TLR response through a feedback activation of STAT3 publication-title: Sci. Rep. doi: 10.1038/srep13414 contributor: fullname: Kim – volume: 17 start-page: e0265196 year: 2022 ident: 10.1016/j.omtn.2023.08.023_bib13 article-title: Effect of stimulation time on the expression of human macrophage polarization markers publication-title: PLoS One doi: 10.1371/journal.pone.0265196 contributor: fullname: Unuvar Purcu – volume: 123 start-page: 170 year: 2002 ident: 10.1016/j.omtn.2023.08.023_bib72 article-title: Interferon β-1b modulates MCP-1 expression and production in relapsing–remitting multiple sclerosis publication-title: J. Neuroimmunol. doi: 10.1016/S0165-5728(01)00487-8 contributor: fullname: Iarlori – volume: 185 start-page: 6226 year: 2010 ident: 10.1016/j.omtn.2023.08.023_bib34 article-title: Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1 publication-title: J. Immunol. doi: 10.4049/jimmunol.1000491 contributor: fullname: Wang – volume: 187 start-page: 2559 year: 2011 ident: 10.1016/j.omtn.2023.08.023_bib81 article-title: IFN-Induced TPR Protein IFIT3 Potentiates Antiviral Signaling by Bridging MAVS and TBK1 publication-title: J. Immunol. doi: 10.4049/jimmunol.1100963 contributor: fullname: Liu – volume: 122 start-page: 2911 year: 2013 ident: 10.1016/j.omtn.2023.08.023_bib25 article-title: Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27 publication-title: Blood doi: 10.1182/blood-2012-12-473017 contributor: fullname: Young – volume: 164 start-page: 6166 year: 2000 ident: 10.1016/j.omtn.2023.08.023_bib8 article-title: M-1/M-2 Macrophages and the Th1/Th2 Paradigm publication-title: J. Immunol. doi: 10.4049/jimmunol.164.12.6166 contributor: fullname: Mills – volume: 29 start-page: 643 year: 2022 ident: 10.1016/j.omtn.2023.08.023_bib31 article-title: Enhancing arginase 2 expression using target site blockers as a strategy to modulate macrophage phenotype publication-title: Mol. Ther. Nucleic Acids doi: 10.1016/j.omtn.2022.08.004 contributor: fullname: De Santi – volume: 11 start-page: 10476 year: 2021 ident: 10.1016/j.omtn.2023.08.023_bib42 article-title: Multiple sclerosis patients have reduced resting and increased activated CD4+CD25+FOXP3+T regulatory cells publication-title: Sci. Rep. doi: 10.1038/s41598-021-88448-5 contributor: fullname: Verma – volume: 9 start-page: ra2 year: 2016 ident: 10.1016/j.omtn.2023.08.023_bib88 article-title: Inclusion bodies enriched for p62 and polyubiquitinated proteins in macrophages protect against atherosclerosis publication-title: Sci. Signal. doi: 10.1126/scisignal.aad5614 contributor: fullname: Sergin – volume: 2018 start-page: 8917804 year: 2018 ident: 10.1016/j.omtn.2023.08.023_bib2 article-title: Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders? publication-title: J. Immunol. Res. contributor: fullname: Parisi – volume: 11 start-page: 750 year: 2011 ident: 10.1016/j.omtn.2023.08.023_bib77 article-title: Transcriptional regulation of macrophage polarization: enabling diversity with identity publication-title: Nat. Rev. Immunol. doi: 10.1038/nri3088 contributor: fullname: Lawrence – volume: 7 start-page: 10521 year: 2016 ident: 10.1016/j.omtn.2023.08.023_bib24 article-title: Endothelial Dicer promotes atherosclerosis and vascular inflammation by miRNA-103-mediated suppression of KLF4 publication-title: Nat. Commun. doi: 10.1038/ncomms10521 contributor: fullname: Hartmann – volume: 5 start-page: 614 year: 2014 ident: 10.1016/j.omtn.2023.08.023_bib20 article-title: Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance publication-title: Front. Immunol. doi: 10.3389/fimmu.2014.00614 contributor: fullname: Wang – volume: 28 start-page: 1190 year: 2020 ident: 10.1016/j.omtn.2023.08.023_bib27 article-title: Precise Targeting of miRNA Sites Restores CFTR Activity in CF Bronchial Epithelial Cells publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2020.02.001 contributor: fullname: De Santi – volume: 10 start-page: 2223 year: 2014 ident: 10.1016/j.omtn.2023.08.023_bib85 article-title: ARG2 impairs endothelial autophagy through regulation of MTOR and PRKAA/AMPK signaling in advanced atherosclerosis publication-title: Autophagy doi: 10.4161/15548627.2014.981789 contributor: fullname: Xiong – volume: 41 start-page: 14 year: 2014 ident: 10.1016/j.omtn.2023.08.023_bib12 article-title: Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines publication-title: Immunity doi: 10.1016/j.immuni.2014.06.008 contributor: fullname: Murray – volume: 4 start-page: 455 year: 1996 ident: 10.1016/j.omtn.2023.08.023_bib60 article-title: TNF regulates the in vivo occupancy of both distal and proximal regulatory regions of the MCP-1/JE gene publication-title: Immunity doi: 10.1016/S1074-7613(00)80412-4 contributor: fullname: Ping – volume: 88 start-page: 123 year: 2015 ident: 10.1016/j.omtn.2023.08.023_bib21 article-title: MiRNA inhibition in tissue engineering and regenerative medicine publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2014.12.006 contributor: fullname: Beavers – volume: 1 start-page: 2 year: 2014 ident: 10.1016/j.omtn.2023.08.023_bib32 article-title: Twenty-five years of studies and trials for the therapeutic application of IL-10 immunomodulating properties. From high doses administration to low dose medicine new paradigm publication-title: J Integr Cardiol contributor: fullname: Fioranelli – volume: 10 start-page: 2759 year: 2019 ident: 10.1016/j.omtn.2023.08.023_bib59 article-title: More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.02759 contributor: fullname: Gschwandtner – volume: 106 start-page: 7113 year: 2009 ident: 10.1016/j.omtn.2023.08.023_bib33 article-title: Inositol phosphatase SHIP1 is a primary target of miR-155 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0902636106 contributor: fullname: O'Connell – volume: 8 start-page: 14887 year: 2017 ident: 10.1016/j.omtn.2023.08.023_bib53 article-title: MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoA publication-title: Oncotarget doi: 10.18632/oncotarget.14841 contributor: fullname: Al-Haidari – volume: 84 start-page: 238 year: 1998 ident: 10.1016/j.omtn.2023.08.023_bib69 article-title: Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions publication-title: J. Neuroimmunol. doi: 10.1016/S0165-5728(97)00208-7 contributor: fullname: Simpson – volume: 13 start-page: 2513 year: 2014 ident: 10.1016/j.omtn.2023.08.023_bib93 article-title: Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ publication-title: Mol. Cell. Proteomics doi: 10.1074/mcp.M113.031591 contributor: fullname: Cox – volume: 39 start-page: 536 year: 2018 ident: 10.1016/j.omtn.2023.08.023_bib4 article-title: Macrophage-Targeted Therapeutics for Metabolic Disease publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2018.03.001 contributor: fullname: Peterson – volume: 1 start-page: 100053 year: 2020 ident: 10.1016/j.omtn.2023.08.023_bib44 article-title: Inferring Multiple Sclerosis Stages from the Blood Transcriptome via Machine Learning publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2020.100053 contributor: fullname: Acquaviva – volume: 4 start-page: 1116 year: 2001 ident: 10.1016/j.omtn.2023.08.023_bib57 article-title: TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination publication-title: Nat. Neurosci. doi: 10.1038/nn738 contributor: fullname: Arnett – volume: 10 start-page: 1794 year: 2011 ident: 10.1016/j.omtn.2023.08.023_bib92 article-title: Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment publication-title: J. Proteome Res. doi: 10.1021/pr101065j contributor: fullname: Cox – volume: 9 start-page: 2645 year: 2018 ident: 10.1016/j.omtn.2023.08.023_bib28 article-title: miR-103 promotes endothelial maladaptation by targeting lncWDR59 publication-title: Nat. Commun. doi: 10.1038/s41467-018-05065-z contributor: fullname: Natarelli – volume: 32 start-page: 257 year: 2014 ident: 10.1016/j.omtn.2023.08.023_bib41 article-title: Immunology of relapse and remission in multiple sclerosis publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev-immunol-032713-120227 contributor: fullname: Steinman – volume: 2019 start-page: 6724903 year: 2019 ident: 10.1016/j.omtn.2023.08.023_bib15 article-title: M2 Macrophages as a Potential Target for Antiatherosclerosis Treatment publication-title: Neural Plast. doi: 10.1155/2019/6724903 contributor: fullname: Bi – volume: 7 start-page: eabf2846 year: 2022 ident: 10.1016/j.omtn.2023.08.023_bib39 article-title: SLAMF7 engagement superactivates macrophages in acute and chronic inflammation publication-title: Sci. Immunol. doi: 10.1126/sciimmunol.abf2846 contributor: fullname: Simmons – volume: 170 start-page: 607 year: 1989 ident: 10.1016/j.omtn.2023.08.023_bib45 article-title: Tumor necrosis factor identified in multiple sclerosis brain publication-title: J. Exp. Med. doi: 10.1084/jem.170.2.607 contributor: fullname: Hofman – volume: 285 start-page: 22576 year: 2010 ident: 10.1016/j.omtn.2023.08.023_bib84 article-title: p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription publication-title: J. Biol. Chem. doi: 10.1074/jbc.M110.118976 contributor: fullname: Jain – volume: 17 start-page: 1485 year: 2018 ident: 10.1016/j.omtn.2023.08.023_bib38 article-title: Proteomic Identification of Interferon-Induced Proteins with Tetratricopeptide Repeats as Markers of M1 Macrophage Polarization publication-title: J. Proteome Res. doi: 10.1021/acs.jproteome.7b00828 contributor: fullname: Huang – volume: 27 start-page: 499 year: 2013 ident: 10.1016/j.omtn.2023.08.023_bib14 article-title: IL-10 mediates the immunoregulatory response in conjugated linoleic acid-induced regression of atherosclerosis publication-title: Faseb. J. doi: 10.1096/fj.12-215442 contributor: fullname: McCarthy – volume: 8 start-page: 1062 year: 2017 ident: 10.1016/j.omtn.2023.08.023_bib19 article-title: MicroRNA: Dynamic Regulators of Macrophage Polarization and Plasticity publication-title: Front. Immunol. doi: 10.3389/fimmu.2017.01062 contributor: fullname: Self-Fordham – volume: 9 start-page: 2290 year: 2020 ident: 10.1016/j.omtn.2023.08.023_bib47 article-title: Re-Examining the Role of TNF in MS Pathogenesis and Therapy publication-title: Cells doi: 10.3390/cells9102290 contributor: fullname: Fresegna |
SSID | ssj0000601262 |
Score | 2.3541842 |
Snippet | The modulation of macrophage phenotype from a pro-inflammatory to an anti-inflammatory state holds therapeutic potential in the treatment of inflammatory... |
SourceID | doaj pubmedcentral proquest crossref elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Publisher |
StartPage | 941 |
SubjectTerms | arginase-2 inflammation macrophages microRNA miR-155 MT: Oligonucleotides: Therapies and Applications multiple sclerosis Original target site blockers |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NixQxEA2yJy-iruL4RQTxIsEk3fno4youq6AnF_YWKp0008pkYGd2Yf-9Vekemb7oReY2E7rTXZXKy1TVe4y9RYRP-SQjwFkj2sYm4U2rRHLZZgyVCRw1OH_7bi8u269X5upI6otqwiZ64OnFfVCNcZBg6LWKrcXrugj4cXGIycth6iOX-ugwNcVgDLxVTVQrq4VGT5s7Zqbiru1mT-Snuqn8nbpZ7EqVvH-xOR2Bz2Xp5NFedP6QPZhBJD-bJv-I3cvlMTs9K3iA3tzxd7yWddb_y0_Z7ZeyHmMtzOLbgeMtBDoV-sGm5tc5FXAA9aTzsfCq2IdjKgMF3wDpe60x4ux4vOO5rImcA0fCNak57LLQ_HYEPlWTc8pD84ib4y-ElE_Y5fnnH58uxCy2IPrWyL1A3CJT8npQfXYugewVxNSb3MnUgfepZqiN7b1SXYzgEHslNXjbyN73uJSfspOyLfkZ4xZMoo5cSF1sO-K_aRNEmfC4B9Z1csXeH152mJ8oHIrNfgYyTSDTBNLH1M2KfSR7_BlJfNj1C_SSMHtJ-JeXrJg5WDPM0GKCDHip8a83f3MwfcB1R8kUKHl7swva25a0Bhq7Yn7hE4uZLn8p47oyeCti5cHg9_x_PNsLdp9mLKquxUt2sr--ya8QKe3j67oofgMPIhQy priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELVKuXBBQEEs0MpIiAsyip34IwdUlYqqIJUTK_Vm2bHDBlhH7G4r9t8z402gkSoOKLfE-Rx75jkzfo-QV4DwMZ8kmdNKsqpUgRlZcRZ0VBFcZXAaFzhffFbn8-rTpbzcI6Pc0fAB17dO7VBPar768fbXz-0xDPh3f2u1-uUGuUxFmek4RXmH3BUQGbHE62KA-zvPDO5YiWHtzO2nTuJTpvGfhKkbMHRaRHkjKp09IPcHOElPdvZ_SPZiekQOThJMpZdb-prmAs_85_yAXH9Mi87nEi3atxRuweCFoUcsc6adYimHw9XptEs0a_dBm8xFQZcOlb4W4HvW1G9pTAuk6YCWboW6DuvIBL3uHN3VlVPMSFMPYfI7gMvHZH724cvpORtkF1hTyWLDAMEUIRjR8iZqHVzRcOdDI2NdhNoZE3KuWqrGcF577zSgsMBbo8qiMQ0M6idkP_UpPiVUORlwba4Lta9qZMKpgvNFgImfU7ouZuTN-LHt8EZ2LDv7ZtE0Fk1jUSlTlDPyHu3xpyUyY-cd_eqrHQaa5aXULri2EdxXCvqh9g427VsfTNHqGZGjNe0AMnbgAS7V_fPmL0fTWxiBmFZxKfZXayuMqlB1oFQzYiZ9YvKk0yOpW2Qub478POAGn_3_qc_JPXxOlnUtXpD9zeoqHgJS2vij3P1_A-xxGD0 priority: 102 providerName: Scholars Portal |
Title | Inhibition of pro-inflammatory signaling in human primary macrophages by enhancing arginase-2 via target site blockers |
URI | https://dx.doi.org/10.1016/j.omtn.2023.08.023 https://www.proquest.com/docview/2864618636 https://pubmed.ncbi.nlm.nih.gov/PMC10494319 https://doaj.org/article/1357adafc21b460497babab7bfbd80f7 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELbanrggSkGER2UkxAW52ZcfeywVVUEK4kCl3iy_liywXpSklfrvO-PdRdkLBxQph8TJOpmx5_PON98Q8g4QPuaTODNScFaVwjPFq5x5GUSArdIbiQXOq6_i6rr6csNvDoiYamESad_Z9iz-7s5iu07cyj-dW048seW31UWOoibgO8tDcgjxd--MPuy_sOmKYqyQGchcfbdDsdOiTHqdRTmLQkmsfxaM9sDmnCq5F3sun5DHI2ik58PkjslBiE_JyXmEA3N3T9_TRONM98dPyN3nuG5tImLRvqFwCQZOBHbvUj6dImHDYA06bSNNHfpgTFKcoJ3Bfl5r2GG21N7TENcoxgEjzQa7N2wDK-hda-jAHqeYd6YWguEvgJDPyPXlp-8XV2xsrsBcxbMdA5ySea-KJndBSm8ylxvrHQ915mujlE8ZaS6cyvPaWiMBa_m8UaLMnHKwdJ-To9jH8IJQYbjHClzja1vVqHdTeWMzD8c7I2SdLciH6c_W4y_SE7nsp0bTaDSNxn6YRbkgH9Eef0ei_nV6od_80KMX6Lzk0njTuCK3lQB3kNbAQ9rGepU1ckH4ZE09QokBIsBXtf-8-NvJ9BrWGSZPTAz97VYXSlTYW6AUC6JmPjGb6fwdcOCk2D057Mv__-gr8gjnyVL3itfkaLe5DW8AD-3sabqPAM-rSp2mpfAAXuYR3w |
link.rule.ids | 230,314,727,780,784,864,885,2102,24318,27924,27925,53791,53793 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKOcAFAQWxPI2EuCB34yR-5Fgqqi10Kw6t1JvlV7oB4qDdbaX-e8ZOgjYXDmhvu87ayYztz5lvvkHoAyD8GE9iRAvOSFlwRyQrKXHCcw9LpdMiJjgvz_nisvx6xa72EB9zYRJp35rmMPxqD0OzStzK362djzyx-fflMY2iJuA783voPitERXdO6f0KDMsuz4ccmZ7O1bXbKHeaF0mxMy8m-1CS659sRztwc0qW3Nl9Th6jRwNsxEf98J6gPR-eooOjAEfm9g5_xInImd6QH6Db07BqTKJi4a7G0AUBNwLLtymijiNlQ8csdNwEnGr0QZukOYFbHSt6rWCN2WBzh31YRTkOaKnXsX7DxpMc3zYa9_xxHCPP2MB2-BNA5DN0efLl4nhBhvIKxJYs2xJAKplzMq-p9UI4nVmqjbPMV5mrtJQuxaQZt5LSyhgtAG05WkteZFZamLzP0X7ogn-BMNfMxRxc7SpTVlHxpnTaZA4OeJqLKpuhT-PDVsMdqZFe9kNF06hoGhUrYubFDH2O9vjbMipgpy-69bUa_EDRggntdG1zakoODiGMho8wtXEyq8UMsdGaagATPUiAv2r-2fn70fQKZloMn-jgu5uNyiUvY3WBgs-QnPjEZKTTX8CFk2b36LIv___Sd-jB4mJ5ps5Oz7-9Qg_jmEmqZfEa7W_XN_4NoKOteZumwh_8bRNl |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSIgLKhTEQgEjIS4o3bz8yLEUVi3Qqgcq9Wb5lW6AONXutlL_PTNOgjYXDii3xImdzNj-nPn8DSHvAeFjPIklWnCWlAV3iWRlljjhuYeh0mmBG5xPz_jxRfn1kl0OrMr1QKsM1jQH4Xd7EJpl5FZet3Y-8sTm56dHGYqagO_Mr109v08esAK8bGul3o_CMPTyfNgn01O6unaDkqd5EVU782IyF0XJ_smUtAU5p4TJrRlosUseD9CRHvZNfELu-fCU7B0GWDa3d_QDjWTO-Jd8j9yehGVjIh2LdjWFKhJwJbB-G6PqFGkbGnei0ybQmKcPykTdCdpqzOq1hHFmTc0d9WGJkhxQUq8wh8PaJzm9bTTtOeQUo8_UwJT4C4DkM3Kx-PLj6DgZUiwktmTpJgG0kjon8zqzXginU5tp4yzzVeoqLaWLcWnGrcyyyhgtAHG5rJa8SK200IGfk53QBf-CUK6Zw3242lWmrFD1pnTapA4WeZqLKp2Rj-PHVsMbqZFi9lOhaRSaRmFWzLyYkU9oj78lUQU7nuhWV2rwBZUVTGina5tnpuTgFMJoOISpjZNpLWaEjdZUA6DogQI8qvln5e9G0yvobRhC0cF3N2uVS15ihoGCz4ic-MSkpdMr4MZRt3t025f_f-tb8vD880J9Pzn79oo8wiYnMZ3FPtnZrG78awBIG_Mm9oQ_0GsUeA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inhibition+of+pro-inflammatory+signaling+in+human+primary+macrophages+by+enhancing+arginase-2+via+target+site+blockers&rft.jtitle=Molecular+therapy.+Nucleic+acids&rft.au=Fitzsimons%2C+Stephen&rft.au=Mu%C3%B1oz-San+Mart%C3%ADn%2C+Mar%C3%ADa&rft.au=Nally%2C+Frances&rft.au=Dillon%2C+Eugene&rft.date=2023-09-12&rft.pub=American+Society+of+Gene+%26+Cell+Therapy&rft.eissn=2162-2531&rft.volume=33&rft.spage=941&rft.epage=959&rft_id=info:doi/10.1016%2Fj.omtn.2023.08.023&rft.externalDBID=PMC10494319 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2162-2531&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2162-2531&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2162-2531&client=summon |